retatrutide vs tesamorelin ...... or both? #glp1 #fyp #foryoupage #tirzepatide #glp1community Retatrutide vs tesamorelin PEPTIDES! The

A health care provider can help patients explore options and find the right approach for them

The Surmount-5 trial had 25% and 30% weight loss reported, and max tolerated dose of tirzepatide caused 36% and 22% of patient hitting those two marks respectively

This makes it particularly well suited to patients who value facial softness and volume, while still wanting measurable lifting, tightening and improvement in skin texture

A new target trial emulation analyzed insurance claims data from over 3,500 pregnancies and found that continuation of GLP-1 RAs during the first trimester of pregnancy was not associated with a substantially increased risk for pregnancy loss, abnormal fetal growth, or major birth defects

Their cost, insurance coverage, and access pathways are entirely separate from the supplement market